Shugo Sakihama
Overview
Explore the profile of Shugo Sakihama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishinakamura H, Shinya S, Irie T, Sakihama S, Naito T, Watanabe K, et al.
Sci Transl Med
. 2025 Feb;
17(785):eadk3160.
PMID: 39937883
Immune checkpoint blockade therapy has been successfully applied in clinical settings as a standard therapy for many cancer types, but its clinical efficacy is restricted to patients with immunologically hot...
2.
Karube K, Sakihama S, Takatori M, Morichika K, Tamaki T, Wada N, et al.
Leuk Res
. 2024 Dec;
148():107634.
PMID: 39689447
Adult T-cell leukemia/lymphoma (ATLL) is a peripheral T-cell lymphoma caused by Human T-cell leukemia virus type 1 (HTLV-1) infection. Although the 5th Edition of the WHO classification (WHO-5) did not...
3.
Tamaki T, Karube K, Sakihama S, Tsuruta Y, Awazawa R, Hayashi M, et al.
Mod Pathol
. 2023 Mar;
36(8):100169.
PMID: 36997002
Adult T-cell leukemia/lymphoma (ATLL) is a mature T-cell tumor caused by human T-lymphotropic virus type 1 (HTLV-1). The typical ATLL immunophenotypes are described in the 2017 World Health Organization Classification...
4.
Sakihama S, Karube K
Cancers (Basel)
. 2022 May;
14(10).
PMID: 35625999
Adult T-cell leukemia/lymphoma (ATLL) is a refractory T-cell neoplasm that develops in human T-cell leukemia virus type-I (HTLV-1) carriers. Large-scale comprehensive genomic analyses have uncovered the landscape of genomic alterations...
5.
Kubo T, Hirayama Y, Sakihama S, Kikuchi T, Hirohashi Y, Tsujiwaki M, et al.
Pathol Res Pract
. 2022 May;
234:153935.
PMID: 35525174
Carriers of oncogenic human T-cell leukemia virus type 1 (HTLV-1) can develop adult T-cell leukemia/lymphoma (ATLL). While an increasing number of animal models of HTLV-1 infection have revealed that malignant...
6.
Mizuguchi M, Takatori M, Sakihama S, Yoshita-Takahashi M, Imaizumi N, Takahashi Y, et al.
Cancer Gene Ther
. 2022 Apr;
29(11):1570-1577.
PMID: 35459881
A massive increase in the number of mature CD4 T-cells in peripheral blood (PB) is a defining characteristic of acute type of adult T-cell leukemia (ATL). To date, the site...
7.
Morichika K, Karube K, Sakihama S, Watanabe R, Kawaki M, Nishi Y, et al.
Am J Surg Pathol
. 2021 Apr;
45(6):832-840.
PMID: 33899787
On the basis of immunohistochemistry, diffuse large B-cell lymphoma (DLBCL) is categorized as a germinal center B-cell (GCB) or non-GCB subtype. Recent integrated genomic analyses have highlighted the importance of...
8.
Karube K, Takatori M, Sakihama S, Tsuruta Y, Miyagi T, Morichika K, et al.
Blood Adv
. 2021 Feb;
5(1):198-206.
PMID: 33570645
Hodgkin and Reed-Sternberg (HRS) cells, a hallmark of classic Hodgkin lymphoma (CHL), are occasionally detected in non-Hodgkin lymphomas, including adult T-cell leukemia/lymphoma (ATLL), a lymphoid neoplasm caused by human T-cell...
9.
Sakihama S, Morichika K, Saito R, Miyara M, Miyagi T, Hayashi M, et al.
Cancer Sci
. 2021 Jan;
112(3):1300-1309.
PMID: 33426772
Genetic alterations in adult T-cell leukemia/lymphoma (ATLL), a T-cell malignancy associated with HTLV-1, and their clinical impacts, especially from the perspective of viral strains, are not fully elucidated. We employed...
10.
Takatori M, Sakihama S, Miyara M, Imaizumi N, Miyagi T, Ohshiro K, et al.
Mod Pathol
. 2020 Aug;
34(1):51-58.
PMID: 32801340
Histopathological distinction between adult T-cell leukemia/lymphoma (ATLL) and other T-cell neoplasms is often challenging. The current gold standard for the accurate diagnosis of ATLL is the Southern blot hybridization (SBH)...